Primary |
High Grade B-cell Lymphoma Burkitt-like Lymphoma |
16.0% |
Meningitis Cryptococcal |
9.7% |
Chronic Lymphocytic Leukaemia Refractory |
6.9% |
Hepatic Candidiasis |
6.9% |
Acute Myeloid Leukaemia |
5.1% |
Fungal Infection |
5.1% |
Chronic Myeloid Leukaemia |
4.6% |
Diffuse Large B-cell Lymphoma |
4.6% |
Immunosuppression |
4.6% |
Pneumonia |
4.6% |
Pyrexia |
4.0% |
Cerebral Toxoplasmosis |
3.4% |
Cytomegalovirus Infection |
3.4% |
Febrile Neutropenia |
3.4% |
Paronychia |
3.4% |
Renal Failure |
3.4% |
Systemic Mycosis |
3.4% |
Oesophageal Candidiasis |
2.9% |
Bronchopulmonary Aspergillosis |
2.3% |
Candidiasis |
2.3% |
|
Tachycardia |
12.3% |
Muscular Weakness |
8.8% |
Neutropenia |
8.8% |
Pyrexia |
8.8% |
Overdose |
7.0% |
Pancytopenia |
7.0% |
Renal Impairment |
7.0% |
Anaphylactic Shock |
5.3% |
Ventricular Fibrillation |
5.3% |
Drug Administration Error |
3.5% |
Fungal Endocarditis |
3.5% |
Hypothermia |
3.5% |
Renal Failure |
3.5% |
Thrombocytopenia |
3.5% |
Weight Increased |
3.5% |
Anaphylactic Reaction |
1.8% |
Angioedema |
1.8% |
Cardiac Arrest |
1.8% |
Cholecystitis |
1.8% |
Congenital Central Nervous System Anomaly |
1.8% |
|
Secondary |
Drug Use For Unknown Indication |
22.7% |
Product Used For Unknown Indication |
21.4% |
Acute Myeloid Leukaemia |
5.6% |
Bronchopulmonary Aspergillosis |
4.8% |
Prophylaxis |
4.1% |
Pyrexia |
4.1% |
Acute Lymphocytic Leukaemia |
3.7% |
Lung Transplant |
3.6% |
Pain |
3.6% |
Systemic Mycosis |
3.2% |
Infection |
3.2% |
Renal Transplant |
2.9% |
Injury Corneal |
2.8% |
Cranial Nerve Disorder |
2.7% |
Gastritis Prophylaxis |
2.4% |
Fungal Infection |
2.2% |
High Grade B-cell Lymphoma Burkitt-like Lymphoma |
2.2% |
Diabetes Mellitus |
1.7% |
Gastrointestinal Disorder |
1.6% |
Candidiasis |
1.5% |
|
Vomiting |
9.6% |
Thrombocytopenia |
8.7% |
Cytolytic Hepatitis |
7.0% |
Hepatic Function Abnormal |
6.1% |
Renal Failure Acute |
6.1% |
White Blood Cell Count Decreased |
6.1% |
Renal Impairment |
5.2% |
Tachycardia |
5.2% |
Toxic Skin Eruption |
5.2% |
Liver Disorder |
4.3% |
Pyrexia |
4.3% |
Sepsis |
4.3% |
Ventricular Fibrillation |
4.3% |
Anaphylactic Shock |
3.5% |
Death |
3.5% |
Henoch-schonlein Purpura |
3.5% |
Memory Impairment |
3.5% |
Tongue Necrosis |
3.5% |
Toxic Epidermal Necrolysis |
3.5% |
Hemiplegia |
2.6% |
|
Concomitant |
Product Used For Unknown Indication |
21.0% |
Prophylaxis |
20.6% |
Drug Use For Unknown Indication |
13.4% |
Multiple Myeloma |
7.1% |
Hiv Infection |
4.8% |
Infection Prophylaxis |
4.1% |
Hypertension |
3.1% |
Rheumatoid Arthritis |
3.1% |
Psoriatic Arthropathy |
2.7% |
Acute Myeloid Leukaemia |
2.6% |
Insomnia |
2.1% |
Pneumonia |
2.1% |
Antifungal Prophylaxis |
2.0% |
Renal Transplant |
2.0% |
Constipation |
2.0% |
Immunosuppression |
1.8% |
Acquired Immunodeficiency Syndrome |
1.5% |
Stem Cell Transplant |
1.4% |
Refractory Cancer |
1.4% |
Juvenile Arthritis |
1.2% |
|
White Blood Cell Count Decreased |
17.1% |
Vomiting |
8.8% |
Thrombocytopenia |
6.9% |
Interstitial Lung Disease |
6.1% |
Pyrexia |
5.1% |
Shock |
5.1% |
Respiratory Failure |
4.8% |
Renal Failure Acute |
4.5% |
Sepsis |
4.5% |
Rash |
4.0% |
Septic Shock |
4.0% |
Pancytopenia |
3.7% |
Staphylococcal Sepsis |
3.7% |
Histiocytosis Haematophagic |
3.5% |
Renal Impairment |
3.5% |
Pneumonia |
3.2% |
Anaemia |
2.9% |
Liver Disorder |
2.9% |
Neutropenia |
2.9% |
Streptococcal Infection |
2.7% |
|
Interacting |
Product Used For Unknown Indication |
75.0% |
Fungal Infection |
16.7% |
Urinary Incontinence |
8.3% |
|
Femoral Neck Fracture |
50.0% |
Prothrombin Level Decreased |
50.0% |
|